Publications by authors named "P Palanza"

Ultimate and proximate levels of analysis offer synergistic explanations can improve the search for causes of disease and their cures. Here we review how several principles of evolutionary biology such as historical contingencies, mismatches, trade-offs, sexual selection and genomic conflict are applied to problems in medicine and psychiatry. The application of evolutionary principles to many other domains of medicine, among them mental disorders, have not received the same reception from preclinical and clinical researchers.

View Article and Find Full Text PDF

Purpose: Puberty is a key phase of growth and development, characterized by psychophysical transformations. It is driven by a combination of genetic, hormonal, and environmental variables. Epigenetic mechanisms, including histone post-translational modifications and chromatin remodeling, microRNAs, and DNA methylation, play important roles in orchestrating the developmental processes.

View Article and Find Full Text PDF
Article Synopsis
  • A study under the European LIFE project is investigating the presence of endocrine-disrupting chemicals (EDCs) in 20 types of infant formulas and in baby bottles and teats, highlighting the risks posed by these chemicals, especially during pregnancy and infancy.* -
  • The study used advanced analytical methods to test for 85 different chemicals, finding low levels of certain harmful substances like phthalates and PAHs in baby products, raising concerns about exposure.* -
  • While some chemicals were absent in accordance with EU regulations in baby bottles, significant levels of EDCs were found in infant formulas, signaling a need for ongoing monitoring and public health measures to protect young children.*
View Article and Find Full Text PDF

Background: The European Food Safety Authority (EFSA) recommended lowering their estimated tolerable daily intake (TDI) for bisphenol A (BPA) 20,000-fold to . BPA is an extensively studied high production volume endocrine disrupting chemical (EDC) associated with a vast array of diseases. Prior risk assessments of BPA by EFSA as well as the US Food and Drug Administration (FDA) have relied on industry-funded studies conducted under good laboratory practice protocols (GLP) requiring guideline end points and detailed record keeping, while also claiming to examine (but rejecting) thousands of published findings by academic scientists.

View Article and Find Full Text PDF